US Market Report for Breast Tissue Markers 2016 - MedCore

  • ID: 3947351
  • Report
  • Region: United States
  • 32 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • C.R. Bard
  • Hologic
  • Mammotome
  • Somatex
  • MORE
Breast tissue markers are placed during roughly 80% of percutaneous breast biopsy procedures. Percutaneous breast biopsy procedures are typically performed using ultrasound guidance, stereotactic guidance or Magnetic Resonance Imaging (MRI) guidance. The volume of ultrasound guided percutaneous biopsy procedures performed annually in the U.S. is expected to increase over the forecast period, while the number of stereotactic-guided breast biopsy procedures is expected to decline.

MRI-guided percutaneous breast biopsy procedure volume is expected to remain relatively stable through 2022. In the past, most breast tissue markers were designed for use with specific biopsy needles. In the future, an increasing number of breast tissue markers are expected to be designed for use with a wide range of biopsy needles.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • C.R. Bard
  • Hologic
  • Mammotome
  • Somatex
  • MORE
Table Of Contents I
List Of Figures Iv
List Of Charts V
Executive Summary
1.1 U.S. Breast Tissue Markers & Breast Localization Wire Market Overview
1.2 Competitive Landscape
1.3 Market Trends
1.4 Key Market Developments
1.5 Markets Included
1.6 Version History
Research Methodology
2.1 Research Scope
2.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Breast Tissue Marker Market
3.1 Market Analysis And Forecast
3.1.1 Breast Tissue Marker Market
3.2 Drivers And Limiters
3.2.1 Market Drivers
3.2.2 Market Limiters
3.3 Competitive Market Share Analysis
Abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • C.R. Bard
  • Hologic
  • Mammotome
  • Somatex
  • MORE
The value of the U.S. breast tissue marker market is expected to increase modestly over the forecast period. Growth in the value of the market will be driven by increasing unit sales and limited by ASP erosion. The increasing incidence of breast cancer and utilization of breast tissue markers in percutaneous breast biopsies as well as axillary lymph node marking are expected to fuel unit sales growth over the next seven years. ASP erosion will be driven by commoditization of breast tissue markers with lower clinical value.
Note: Product cover images may vary from those shown
5 of 5
Mammotome
Hologic
C.R. Bard
Somatex
Others Include: Argon Medical, Becton Dickinson, Mermaid Medical, Scion Medical Technologies, etc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll